Results 201 to 210 of about 58,717 (264)

Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. [PDF]

open access: yesFront Endocrinol (Lausanne)
Abdul Jafar NK   +9 more
europepmc   +1 more source

A Comparative Study of Polysomnography‐Derived Sleep Disturbance in People Living With Multiple Sclerosis Compared to Matched Controls From the General Population

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Sleep structure and sleep disorders were compared between people with multiple sclerosis (MS; n = 39) and age, sex, and BMI‐matched members of the general population (n = 39) using overnight polysomnography (PSG). Compared to population controls, people with MS had a higher prevalence of periodic limb movement disorder (PLMD; 59% vs.
Amy C. Reynolds   +8 more
wiley   +1 more source

Autonomic Control of Heart Rate During Sleep Is Depressed in Young Children With Prader–Willi Syndrome

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Children with Prader–Willi syndrome are at increased risk of both obstructive and central sleep apnoea. In addition, these children have impaired autonomic control, which may be exacerbated by sleep apnoea. The aim of this study was to compare autonomic control using heart rate variability and nocturnal dipping of heart rate in children with ...
Okkes R. Patoglu   +6 more
wiley   +1 more source

The Effect of Digital Cognitive Behavioural Therapy for Insomnia in People With Co‐Morbid Insomnia and Sleep Apnoea (COMISA): A Pilot Randomised Controlled Trial

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Co‐morbid insomnia and sleep apnoea (COMISA) is a prevalent and debilitating condition. Cognitive behavioural therapy for insomnia (CBTi) is an effective but largely inaccessible treatment in patients with COMISA. We aimed to test a self‐guided interactive digital CBTi program tailored for COMISA and insomnia alone.
Alexander Sweetman   +3 more
wiley   +1 more source

The Effects of Daridorexant on Patients With Comorbid Insomnia Disorder and Untreated Mild Obstructive Sleep Apnoea: A Post Hoc Subgroup Analysis of a Phase 3, Randomised Clinical Trial

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Daridorexant, a dual orexin receptor antagonist, is approved for the treatment of insomnia disorder in adults. Approximately 30%–35% of patients with insomnia disorder also have obstructive sleep apnoea (OSA) of any severity. It is unclear whether sleep medications provide safe and effective treatment for insomnia in these patients.
Christopher J. Lettieri   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy